Desheng View - What are the pain points of the IVD raw material industry?

In recent years, with the update and iteration of technology and the expansion of financing scale, the rapid development of China's IVD market can be seen to the naked eye, and the upstream IVD raw material industry has also received extensive attention. glory. And many enterprises have been got a glory markets. But is it really "a piece of glory? In fact, the hidden pain points have always existed, why is this? Next, Desheng will give you a specific analysis.

1. Unbalanced distribution of product types of domestic raw material enterprises

The field of IVD is mainly divided into three fields, namely the field of biochemical diagnosis, the field of immunodiagnosis and the field of molecular diagnosis. Among them, the immunodiagnosis field dominated by chemiluminescence has a large market share. Although the growth rate of the traditional biochemical diagnosis field is slow, it still occupies the second place. In the field of biochemical diagnosis, most of the detection items are based on the enzyme method.The raw materials and special substrates are monopolized by some big brand enterprises, which makes the domestic raw material manufacturers become only a handful, and the types are unevenly distributed and gradually reduced.

2. Downstream reagent manufacturers continue to expand to upstream raw materials

Due to the product quality problems of upstream raw materials and the shortage of supply, many downstream reagent manufacturers continue to break the original form and expand to upstream raw materials. Although it is understandable to do so, it objectively compresses the market share of raw material factories.

Based on these two points, Desheng expressed some of his own opinions. In addition, many downstream reagent manufacturers invested a lot of money to form raw material teams for large-scale production, but the specific development and selection of varieties did not take into account the development level of the actual raw material market. Some raw material manufacturers are already very mature, and there is no need to develop them by themselves. The cost of investment may be greater than imagined, and there is no advantage in selling products of the same category in the future, so naturally they will not be able to obtain high profits. .

Desheng biochemical has been committed to the development and production of raw materials for diagnostic reagents for up to 17 years. Not only has rich experience, but also has a clear understanding of the entire IVD market, and has developed a product line that is unique to itself, so it has not been eliminated by the market for many years. On the contrary, it has made great progress and sold all kinds of products overseas. I believe that in the near future, Desheng, as a veteran manufacturer, will eventually rank first in the IVD industry! If you have requirements for raw materials of diagnostic reagents, please click on the website for inquiry.